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Background: Leadership behaviour in complex networks is under-researched, and little has been written
concerning leadership of translational research networks (TRNs) that take discoveries made ‘at the bench’ and
translate them into practices used ‘at the bedside.’ Understanding leaders’ opportunities and behaviours within
TRNs working to solve this key problem in implementing evidence into clinical practice is therefore important. This
study explored the network position of governing body members and perceptions of their role in a new TRN in
Sydney, Australia. The paper asks three questions: Firstly, do the formal, mandated leaders of this TRN hold key
positions of centrality or brokerage in the informal social network of collaborative ties? Secondly, if so, do they
recognise the leadership opportunities that their network positions afford them? Thirdly, what activities associated
with these key roles do they believe will maximise the TRN’s success?
Methods: Semi-structured interviews of all 14 governing body members conducted in early 2012 explored
perceptions of their roles and sought comments on a list of activities drawn from review of successful
transdisciplinary collaboratives combined with central and brokerage roles. An on-line, whole network survey of all
68 TRN members sought to understand and map existing collaborative connections. Leaders’ positions in the
network were assessed using UCInet, and graphs were generated in NetDraw.
Results: Social network analysis identified that governing body members had high centrality and high brokerage
potential in the informal network of work-related ties. Interviews showed perceived challenges including ‘silos’ and
the mismatch between academic and clinical goals of research. Governing body members recognised their central
positions, which would facilitate the leadership roles of leading, making decisions, and providing expert advice
necessary for the co-ordination of effort and relevant input across domains. Brokerage potential was recognised in
their clearly understood role of representing a specialty, campus or research group on the governing body to
provide strategic linkages. Facilitation, mentoring and resolving conflicts within more localised project teams were
spoken of as something ‘we do all the time anyway,’ as well as something they would do if called upon. These
leadership roles are all linked with successful collaborative endeavours in other fields.
Conclusions: This paper links the empirical findings of the social network analysis with the qualitative findings of
the interviews to show that the leaders’ perceptions of their roles accord with both the potential inherent in their
network positions as well as actual activities known to increase the success of transdisciplinary teams.
Understanding this is key to successful TRNs.
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Introduction
If the wealth of biomedical research is to be translated
into useful clinical practice and routine health decision-
making, new knowledge must be taken out of the highly
controlled laboratory environment and applied and under-
stood in the messiness and complexity of actual patient
and clinical service realities. Expertise and understand-
ing from both arenas are essential to work out ways to
make this happen. Translational research networks (TRNs)
(Collaboration for Leadership in Applied Health Research
and Care (CLAHRCs) in the UK [1] and health science al-
liances elsewhere) are a strategy to overcome the gaps be-
tween biomedical researchers and clinicians. They involve
setting up an administrative structure to provide funding
and shared resources, and a flatter, less hierarchical social
structure than those found in individual hospitals or
universitites so as to maximize collaboration, innovation
and knowledge transfer across different disciplines, organi-
sations, sites and specialties [2-9].
Despite the importance, little research assesses leader-
ship behaviours in TRNs. Unlike university- or industry-
based transdisciplinary teams, TRNs face problems of
clinical service constraints and achieving outcomes, that
while benefitting patients, may receive little academic
kudos. Leaders of a network focused on translational re-
search must manage differences in technical language,
paradigms and approaches between researchers and clini-
cians. They need to find ways to promote strategic collabor-
ation across disciplines, organisations and sites without
overwhelming members with a deluge of new contacts [10].
Leadership and relationships
One way of looking at leadership in these complex net-
works is to use a social network approach in which graph
theory is used to quantify and explore the complex set of
ties (relationships and interactions) between members
[11,12]. Rather than considering the attributes or human
capital held by members, such as expertise or skill sets, so-
cial network analysis considers members’ social capital.
Here, we use social capital in the sense that Burt and
Coleman use it; that is, to indicate the advantage that
comes from a member’s individual positions within the
overall configuration of their web of relationships [13,14].
Translational research networks are social networks that,
in contrast to their formal structure, are defined by ties of
communication or collaboration between members. Key
players in social network terms are network members (‘ac-
tors’) who hold powerful or influential positions with high
social capital [15], but it is not always true that key players
are the mandated leaders [10,16]. Central actors are key
players who interact with the most other actors, while
brokers form links between isolated clusters, aiding cohe-
sion through mediation behaviours [17]. Actors can holdboth central and brokerage positions at the same time [12].
This study combined a social network survey with semi-
structured interviews to explore the potential available to
leaders through their network positions, and perceptions
of their leadership roles. This research complements a lar-
ger research program exploring the role of key players in
healthcare networks, and ultimately how their work can be
supported and enhanced [18].
Centrality and brokerage have been suggested as posi-
tions that provide opportunities for effective leadership
activities in complex networks [19-23]. Gray proposed a
model of leadership for transdisciplinary teams, noting
that leaders in central and brokerage positions within
the network of members were best able to fulfil the vari-
ous activities [19]. She grouped these activities into cogni-
tive tasks, structural tasks and processual tasks. Cognitive
tasks include communicating a vision of how members
can overcome their discipline-specific assumptions and
paradigms and learn to innovate and work together, as
well as making decisions about such things as the com-
position of teams, which projects to support, and resource
allocation. Structural activities involve co-ordination of
the members and efficient information transfer, while pro-
cessual activities are focused on ensuring that individual
team interactions are constructive and any conflict is
managed. Drawing on Stokol and colleagues’ review of
geographically dispersed transdisciplinary teams [23], she
also indicated that large and dispersed teams, such as the
network studied here, require multiple leaders, a finding
echoed by Greenfield and colleagues in a complex clinical
setting [24]. These distributed leaders’ actions involved
co-ordinating effort, ensuring information transfer across
the network, and carrying out processual tasks for their
local project groups.
Barriers and enablers of translational research
Leaders’ behaviours and actions will be dependent not
only on their position within the network but also on
how they view the challenges facing the network. The
literature reports four main challenges to the successful
undertaking of translation research: structural, financial,
intellectual and cultural factors. Structural challenges in-
clude the pressures of clinical service delivery, leaving
clinicians little time for research [4,8,25-27]. Key finan-
cial challenges are the unreliability of funding [8,28], and
lack of a recognised career path for translational researchers
[4,28]. Intellectual challenges include the need to under-
stand unique research designs [4,29], and legal and regu-
latory requirements [28,30]. Lack of standardisation of
clinical trial protocols and data recording [2,3,27], and in-
ability to access results from previous trials or research pro-
grams also hinders translation [2,3,8]. The formation of a
network seeks to address these three factors by providing
an interorganisational structure that can deliver reliable
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portive infrastructure.
The fourth challenge to translational research effective-
ness is the mediating role of cultural factors. One mani-
festation is the differing paradigms, language and modus
operandi of scientists and clinicians, which Dauphinée
and Martin call the new ‘two cultures’ [8] after C.P. Snow’s
use of the phrase to describe the lack of understanding be-
tween science and the arts [31]. These differences need to
be managed to prevent miscommunications and team
conflict as well as to smooth the dissemination of findings
once teams have completed their projects [8,25,28,32].
Centrally located leaders who have relevant expertise
and a vision of how successful translational research is
achieved [23], or who can act as influential opinion leaders
for the adoption of new findings, or who use their posi-
tions as brokers between the two cultures are well placed
to mediate and smooth members’ interactions [19].
Aim
Given the identified importance of leaders in TRNs and
the limited empirical research of this area, the aim of
this study was to identify how mandated leaders of a
TRN use their network position to influence. This aim
was advanced by collectively answering three questions:
Firstly, do the formal, mandated leaders of this TRN
hold key positions of centrality or brokerage in the infor-
mal social network of collaborative ties? Secondly, if so,
do they recognise the leadership opportunities that their
network positions afford them? Thirdly, what activities
associated with these key roles of centrality and broker-
age do they believe will maximise the TRN’s success and
do these activities accord with Gray’s leadership model?
Methods
Setting
The setting is a translational cancer research network
(hereafter the TRN) in Sydney, Australia, with 68 foun-
dation members: clinicians based primarily in hospitals,
and university-based biomedical and health services re-
searchers. The TRN established a 14-member governing
body to provide leadership and co-ordination of the net-
work, including allocation of funds for 12-month projects
and conference, travel and student grants. The governing
body is made up of the network director, network manager,
five senior leads in the disciplinary domains of basic sci-
ence, health systems, clinical practice, primary health and
pathology, and seven other members selected for their key
knowledge or experience. Four members are primarily cli-
nicians, six are researchers and three clinician-researchers
with joint university and hospital appointments. The
overarching goal of the network was ‘Taking science to
practice’ and focussed on translating new, clinically proven
knowledge of cancer processes, diagnostic or treatmenttechniques into routine clinical practice and health
decision-making [6,27].
The TRN officially commenced in July 2011, and for-
mal collaborations between members began in January
2012. Data collection for this study commenced in early
2012 at a time when there had been little official TRN
contact between members. However, the TRN is embed-
ded in a pre-existing and complex interorganisational
network of long-standing research and teaching arrange-
ments. TRN activities and funded projects do not dis-
place existing and ongoing research such as National
Health and Medical Research Council funded projects.
At its inception, the TRN was already a collaborative effort
with core group members who prepared and submitted
the proposal to the funding body. Ethics approvals for the
interview and online survey were obtained from the Uni-
versity of New South Wales (HREC 09085), appropriate
regional health authority and site-specific committees, and
all participants gave written consent.
Social network data
All 68 members of the TRN were invited to complete an
on-line survey in March 2012 [18]. Respondents were
given a list of all members showing their name, job title
and primary place of work and asked to indicate which
members they knew before the TRN commenced. They
were asked to select one of four categories to describe
the type of relationship: collaborated with (e.g., on a funded
project), worked with (e.g., shared care of patients or in the
same research group), socialised with (i.e., outside of work),
or knew by professional reputation (e.g., familiar with their
published work, colleague of a colleague). As social ties
were scant and were all reciprocated with either ‘collabo-
rated’ or ‘worked with’ ties, all answers were combined to
produce the Whole TRN Collaboration Network. Key
player parameters were calculated for each member using
UCInet v6 social network analysis software [33], and net-
work diagrams were generated using NetDraw [34].
Qualitative data
Semi-structured interviews were conducted with all 14
governing body members in early 2012. A total of 12 in-
terviews were conducted face-to-face and two over the
phone, lasting 30 to 45 minutes each. All interviews were
recorded, transcribed, and qualitative data analysed with
the assistance of NVivo 10 software.
The interview examined perceptions of the partici-
pant’s role and the activities he or she believed would
achieve that role. A combination of deductive and inductive
approaches was employed via a selection of open-ended
and prompted questions. Opportunities were given to par-
ticipants to talk freely about unanticipated challenges inher-
ent in the new TRN structure. Interviews were conducted
by a single researcher (JL) who had a background as a
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taken during interviews to ensure rigour through the use of
structured, standardised questions and by checking partici-
pants’ meaning as needed (by asking reflexive questions) to
ensure clarity of interpretation. Concepts and themes were
coded independently by two reviewers (JL and JW) and
finalised using discussion.
The first section of the interview asked participants to de-
scribe the network’s main objectives and the challenges they
faced in achieving them. Other questions asked how they
would measure network success formally and informally.
The second section asked open-ended and unprompted
questions about the participant’s role within the network
up until now and in the future. Participants were then
shown a list of activities that have been associated with
central and brokerage positions [35], and which Gray
equates with successful leadership in complex networks
(see Table 1). Participants were asked to indicate which
ones they were doing now or expected to do in the future
to further the aims of the network, and to comment on
their choices.
Results
Social network analysis
The governing body was shown to be a well-connected
group with positions conveying high centrality and broker-
age potential in the Whole TRN Collaboration Network.
Social network graphs are shown in Figure 1(a) and 1(b).
The density of governing body members is 0.62, meaning
that 62% of all possible linkages are present (Figure 1(a)).
There were no isolates: members not already known to at
least one other member.
Independent sample t-tests were used to compare mean
degree (a measure of centrality), mean betweenness, and
mean effective size (measures of brokerage potential [17])
of govering body members and other network members.Table 1 Central leadership positions, brokerage positions and
Network role Position Role Activity
Central actor Interacts with the
most other members
Leader Leading
co-ordi
High degree Expert, opinion leader Leading
mentor
Broker Links other who are
not linked themselves
Boundary spanner,
bridge, liaison
Represe
a go-be
High betweenness,
high effective size
Bridge, broker Linking
commu
Knowledge broker, mediator,
cultural boundary-spanner
Providin
conflict
commu
Gatekeeper Control
or reso
Note. Activities listed in the column marked ‘Activities’ were shown to the governin
are you doing now or expect to do in the future to further the aims of the networkThe t-tests were statististically significant across all three
measures (see Table 2 and Figure 2(a) to (c)), showing that
governing body members held more key positions and
had a higher social capital than did their other colleagues.
Moreover, eight of the nine members with the highest
indegree, and eight of the eleven members with the
highest betweenness centrality, were members of the
governing body.
Interview data
All the participants described the main objective of the
TRN as the translation of research into clinically useful
outcomes, echoing the network’s vision statement. A
total of 9 of the 14 participants spoke in terms of net-
work outcomes that would directly affect the care that
patients receive, while others spoke of engaging and co-
ordinating people, providing research infrastructure,
driving dissemination of findings, and facilitating collab-
orative links.
‘What are the challenges for the TRN?’
Ten participants mentioned the presence and persistence
of silos - fragmented, insular and sometimes competitive
subgroups - as a significant challenge. For example: ‘I have
seen as much rivalry amongst people working in [the same
field] from different sites, different universities, as I have
collaboration among them’ (Interviewee XA24, researcher).
Another significant challenge mentioned by the major-
ity of participants was the mismatch of researcher and
clinician expectations, paradigms and methods. For ex-
ample: ‘A lot of research is driven by academic parame-
ters … winning grants and publishing papers… And the
trouble is academic parameters have no relationship
whatsoever to outcomes for patients. No-one cares’
(Interviewee WA23, researcher). A clinician stated, ‘[The
TRN meeting] was scheduled at “professor time” whichthe activities associated with each
Comment
, making decisions,
nating, communicating
The actor interacts with the most
other actors [15,36]
, giving expert advice,
ing, communicating
The actor is a credible source of
information and can lead change [37,38]
nting, advocating, being
tween, communicating
The actor links to a person or group
outside of the network [17,39]
, being a go-between,
nicating
The actor facilitates collaboration between
actors within the network [40,41]
g expert advice, resolving
s, facilitating, interpreting,
nicating
The actor stands between other network
members and facilitates the interaction [19,42]
ling the flow of information
urces, communicating
May be positive (stopping unnecessary
overload) or negative (impeding access;
setting up inequalities) [38,39]
g body members as part of the interview and asked: ‘Which of these activities
?’
Figure 1 (See legend on next page.)
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Figure 1 (a). Social network diagram of governing body members answering the question: ‘Which other governing body members did
you know before the TRN started?’ (b). Social network diagram of whole TRN answering the question: ‘Which members did you know before
the TRN started?’ Governing body members are black circles; other members are grey triangles.
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viewee UC60). Other issues raised were how to manage
the diversity of stakeholders and how to engage those
clinicians not already doing research.
‘What is your role?’
Two open-ended questions, ‘What has been your role so
far in the TRN?’ and ‘What do you think will be your
role in the future?’ were asked early in the interview.
Ten of the 14 participants limited their answer to the
former question to saying they had helped to draft (or had
commented on) the initial grant proposal for the network
and had attended the first governing body meeting. Four
others had worked on TRN infrastructure projects such as
setting up a database or recruiting translational research
project officers. Future roles were far more diverse. People
working on infrastructure projects saw that expanding
or at least continuing. Four thought their role would be
mainly providing expert advice, and one thought he could
mentor and guide younger researchers’ projects in his field
of expertise. Other answers included encouraging engage-
ment among colleagues, advocating for their own research
group, administering TRN funds, and leadership and gov-
ernance of the network.
Central actor roles and activities: leading, decision-making,
co-ordinating, communicating, and opinion leading
All but two of the participants considered being on the
governing body presupposed they would be undertaking
leading and decision-making activities. The two that dis-
agreed seemed to have different reasons for saying so. The
first, a clinician-researcher who felt that the new way of
accessing research grants from the funding body would
disadvantage his research group, made a distinction be-
tween leading and making decisions: ‘Leading? Definitely
not. I mean [the network director] is the leader but mak-
ing decisions as opposed to leading, yes, because the char-
ter of this executive is that they’re supposed to ultimatelyTable 2 Results of t-tests comparing mean degree, betweenn
other members of the TRN
N Mean
Degree Governing body 14 34.93
Other members 38 25.39
Betweenness Governing body 14 40.27
Other members 38 16.78
Effective size Governing body 14 12.22
Other members 38 6.84decide on the projects that get support. So, yes to that
[making decisions] but no to that [leading]… The person
who has the money controls the shots’ (Interviewee UA21,
clinician-researcher). The other participant felt strongly
that their role was more as an expert consultant. Thus,
she stated, ‘I don’t think I’ll be a leader or making deci-
sions really… My role is to provide input into the ideas
that the researchers may have; whether it will work in the
clinical setting’ (Interviewee GA7, clinician).
Both the formal written objectives and participants’
discourse on TRN objectives emphasised the importance
of the central actor role of co-ordinating translational re-
search effort across the sites and different disciplines.
The work towards developing shared resources and sup-
port from project officers was discussed as a means of
supporting that effort once collaborations had been started
and was largely viewed as part of the role of the network
manager and the project officers. Half of the participants
agreed they would have a co-ordinating role, but it was
generally qualified by limiting it to projects undertaken in
their department or field of expertise, implying that they
recognised their centrality in those areas but not network-
wide. Seven participants said they would not, or would
‘probably’ not co-ordinate.
The network manager spoke at length about her role
in co-ordinating members, the challenge it presented,
and how she intended to achieve it: ‘I have made an ef-
fort to see almost all of the [governing body] members
at least once at their location… I’ve had email contact
with everyone on this list [68 network members]’ (Inter-
viewee JA10, research manager).
Increasing the co-ordination and collaboration of siloed
researchers and clinicians as a network objective was
mentioned by 10 participants and was seen as a significant
challenge and an important but difficult goal to achieve.
Five people spoke of how the TRN hoped to change the
culture of research, reducing the impact of silos and mak-
ing it easier to form interorganisational collaborations andess and effective size of governing body members and
Standard deviation t (df) Significance
10.57 3.15 0.003
9.35 (50)
32.36 2.85 0.006
23.83 (50)
6.57 3.19 0.002
4.90 (50)
Figure 2 (a) to (c): Comparison of key player measures of governing body members and rank and file TRN members.
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clinicians and two researchers were sceptical that the
current network configuration would be adequate to do
this, however.
Every participant acknowledged a role of providing ex-
pert advice, either to the governing body or to members,
and this was seen as a valuable asset. Knowing theinstitutions and broader contexts in which the network
was situated was also considered ‘expert knowledge.’ A
clinician stated, ‘The other reason I’m there [on the
governing body] is because I have been here [Hospital #1]
for 20 years. I actually know the place reasonably well and
all the wheeling and dealing that gets done around a hos-
pital’ (Interviewee LB38).
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body members was mentioned by three people as a sub-
ject that had been discussed in the first governing body
meeting. Two people insisted it was not part of their role,
neither having current supervisory roles with students.
For the other 12 participants, mentoring was accepted as
crucially important in the goal to make translational re-
search sustainable.
Communication is an essential activity associated with
both leadership and brokerage roles. In total, 11 mem-
bers said they would be communicating as part of their
role. Maintaining focus was identified by three partici-
pants as a challenge to the network. Four participants
saw their leadership role on the governing body as keep-
ing important issues for the network in focus, such as
producing patient-centred outcomes and reflection on
their evolving role. Two participants stated that they saw
their role on the governing body as one of challenging
the others, which may also be labelled as a leadership
role akin to opinion-leading. Both used the phrase ‘I’m
the only one who can say it.’ As said by a reasearcher,
‘You have got to deliver something [for patients] that is
serious. My role in the Council is to say those kinds of
things… I think probably I’m the only person in the
room who can say it because I’m a basic scientist …
therefore that gives me the right’ (Interviewee WA23).
Another researcher said, ‘I’ve said things that no-one else
in the room would say like “are we really using the best
evidence possible to deliver care to the patients, because
our research tells us that there’s a lot of people who are
not,” and you know already none of the clinicians in the
room would have said that but I was able to’ (Inter-
viewee EA5).
Brokerage roles and activities: representing, bridging,
mediating, resolving conflict, and gate keeping
While no participant used the word ‘broker’ in the
open-ended question on roles in the TRN, all partici-
pants selected one or more brokerage activities from the
list provided. Most participants saw their well-connected,
central positions within their own department or research
area as an asset for the network as it allowed them to take
on brokerage roles and use these links for the network.
The terms of reference for the governing body explicitly
stated that members were chosen for their ability to repre-
sent certain disciplinary skills and the key campuses in-
volved. All participants were quite clear about their formal
representative role on the governing body, and some partic-
ipants also claimed to represent nurses, surgeons, patholo-
gists and their own research groups. Some felt they had
several representative roles: ‘[I have] dual roles: representing
education and [Hospital #3]’ (Interviewee MB39, clinician).
Representation is a brokerage role in that the actor
links the group they represent to the network. This is animportant role because it gives the network access to a
diverse and rich source of ideas and viewpoints yet without
making it unmanageable with large numbers of people
[13,40]. One of the network’s strategies was to ensure rep-
resentation on the governing body from health services re-
searchers (specialists in evidence-creation, implementation
and evaluation), primary health researchers (often omitted
as not hospital-based), and health economists (specialists
in value for money, project viability and sustainability). A
researcher stated, ‘Having a [TRN] that has this group of
expertise available to it would really put it ahead of the
pack’ (Interviewee EB5).
All participants were clear that their role would in-
clude brokerage in terms of facilitating actual research
projects undertaken in their area, though several used
the qualifying phrase ‘if I was asked.’ Words chosen for
this role were: being a go-between, liaising or bridging.
A clinician stated, ‘You know I might say look, go and
see so and so; he might be able to sort that out’ (Inter-
viewee LB38, clinician).
‘Resolving conflict within teams’ was interpreted as the
inevitable part of any research collaboration, more about
personalities involved than as a result of a mismatch of
clinicians’ and scientists’ expectations. As stated by a
clinician, ‘Resolving conflicts within research teams, yep.
We do a certain amount of that unfortunately. There’s
always little interpersonal things niggling away’ (Inter-
viewee YA25). Participants were split between thinking it
was their role (five participants) to resolve these types of
conflicts, and thinking it was not (seven). Four people
thought it was the role of the governing body or network
director but not them individually.
As well as providing expert knowledge, three partici-
pants also described situations where their role was
more like that of an interpreter or translator. All three
were in highly specialised roles. For example: ‘I think we
do have, like all disciplines, a set of jargon and a set of
words that are used and it will be definitely part of my
role to interpret that and explain that … also … looking
at a set of results or issues and saying well, from my per-
spective this is how I would look at it’ (Interviewee XA24,
researcher).
Gatekeeping was discussed by two participants in
terms of the unpalatable governing body role of allocat-
ing research grants where they may have to ‘say no’ to
their peers. Two other participants described them-
selves as people who open or slip through gates to facili-
tate access to resources. One clinician saw gatekeeping
as a positive and useful role: ‘This person wanted to
meet everybody and I said … that’s not appropriate. You
need to tell me exactly what you want and then I can
give you who you need to meet with. So I understand
that I am the gatekeeper’ (Interviewee GA7, clinician-
manager).
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members was that of boundary spanning; i.e., linking to
people outside of the TRN in order to improve TRN
outcomes. The network manager discussed meeting with
managers of other newly formed TRNs supported by the
same funding body but which had a different structure.
One of the other researchers said he was looking for-
ward to consulting with a research group from another
of these TRNs, as he felt the previous siloed and com-
petitive culture of conducting research was changing.
Discussion
We set out to answer three questions to illuminate a core
problem in implementation science. The first asked: do
the formal, mandated leaders of a TRN hold key positions
of centrality or brokerage in the informal social network
of collaborative ties? We have shown this to be so in this
case. This is a contribution to the literature on the role of
leaders in networks. While other studies have shown that
appointed leaders do not always turn out to be key players
in their networks when formally evaluated with social net-
work analysis [10,20], it may well be that the pattern is dif-
ferent in TRNs. These are networks that have a specific
purpose of applying evidence in practice. Consequently,
the leaders chosen sit in key formal positions that affect
both the questions that are researched, and the decision to
apply new ideas in practice. Given the increasing use of
TRNs, along with the limited empiricial focus on their col-
laborative functioning, this is a key contribution.
In relation to the second and third questions, partici-
pants did recognise and were very clear on their positions
as being centrally involved in the web of member interac-
tions and knowing the skills and expertise of members so
that strategic linkages could be facilitated. The brokerage
role of representing a domain such as pathology, a profes-
sional group such as nursing or an individual site, was
seen in terms of co-ordinating effort across diverse areas
and leveraging expertise from a range of stakeholders [35].
Activities associated with Gray’s leadership model were all
recognised and included.
The significant challenge of bridging between clinical
and research group silos was identified by participants
and accords with other research on gaps and clusters in
healthcare, translational research, and the academic sector
[8,43,44]. Brokers are able to bridge these groups, often by
‘having a foot in each camp.’ Here, clinician-researchers
with an academic position and a clinical position have an
insight into both domains and understand the specialised
language and tacit knowledge of each. This can foster trust
and respect and facilitate interactions [19,42]. Almost all
of the governing body members had previous experience
of translational research, which also facilitates understand-
ing through knowledge of the particular norms, routines
and expectations of translational teams.The acceptance of the processual tasks of facilitating
and resolving conflict among research teams also ac-
cords well with Gray’s model of distributed leadership,
even if there was some reluctance to offer their services
without invitation [19]. Once again, the dual aspects of
human capital and social capital in the leadership role are
apparent. Human capital is used to understand the issues
involved and social capital to act as an effective facilitator,
conflict resolver, or go-between to direct team members
to the help or resources they need.
Participant UA21’s distinction between decision-making
and leading was an unexpected one and stood out from the
rest of the participants’ answers. This clinician-researcher
equated the TRN director’s ‘power’ with ‘holding the purse
strings,’ saying that the director and their close associates
were therefore the ones leading or ‘calling the shots.’ UA21
further indicated that changes in the administration of re-
search funding through the TRN was likely to have a nega-
tive impact on their research group and was an untested
and difficult model.
The TRN manager directed a great deal of effort on
commencement in the position into communicating with
every member, often visiting them in their own workplace
to establish a rapport and better understand their needs.
This recognition and investment in social capital meant
that the manager was in a good position to leverage devel-
opment of TRN resources and to facilitate members’ ac-
cess to expertise and resources.
Strengths, limitations and significance
This study was a full census, not a sample, so although
the number of participants of the interviews was only 14,
all appointed leaders of the TRN provided the full range of
views. Further, while this study was based on a single TRN
with a particular structure, the case study approach allows
for a more detailed understanding of the interrelationships
and perceptions of the governing board members. Little
empirical research has been conducted on either the leader-
ship roles in collaborative healthcare networks or brokerage
roles in that context, and so this study provides insights
into how leaders of other translational research or transdis-
ciplinary endeavours may frame their roles.
Conclusions
The governing body members were confirmed as key
players by virtue of their position within the whole TRN
network of members, showing their potential as both cen-
tral actors and brokers. They were more centrally placed
and interacted with more members on average than did
the other members. They also acted as a bridge between
members who did not know each other more often than
most other members.
Participants had a clear understanding of the TRN’s
objectives and vision, and this was well aligned with the
Long et al. Implementation Science 2013, 8:122 Page 10 of 11
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perceived role elicited a range of answers, but apart from
‘encouraging engagement among my colleagues’ and
boundary spanning, all the activities had been antici-
pated and were included on the prompt list. Overall, our
expectations of the 14 mandated key players’ perceived
roles were largely confirmed. Leading, making decisions,
and providing expert advice were almost unanimously
selected as part of the leadership role of a governing
body member. Brokerage activities were also seen as a
component of their role, although some brokerage activ-
ities were chosen more often than others. Representing a
specialty, campus or research group on the governing
body was nominated by everyone, with facilitation and
mentoring research teams chosen by all but two. Although
the term was never used, there was a strong perception
they were acting as a ‘brain trust’ for the members in the
sense that they were all experts and willing to give advice.
There seemed to be a distinction between roles that
participants took on as part of the TRN that were just
for the TRN – for example, making decisions on funding
allocation, infrastructure and future directions – and fa-
cilitative roles that ‘we do all the time,’ like mentoring
and troubleshooting problems within project teams. The
TRN is a hybrid of a hierarchical, and a flatter, enclave
style of network [45]. Stokol and colleagues report that
the presence of multiple leaders and champions and a
non-hierarchical membership that allows autonomy while
encouraging participatory goal setting are all key factors
for effective transdisciplinary teams [23]. Gray also notes
this point and adds the importance of co-ordination be-
tween these multiple leaders or local champions [19].
Governing body members’ willingness to mentor and facili-
tate research teams (even if only ‘when required’) makes
them local leaders and champions, as does the activity of
encouraging engagement of colleagues not already engaged
in translational research. At the same time, the governing
body structure allowed co-ordination and the representa-
tion of discipline, specialty, campus or research group and
was seen as a means of bridging the ‘two cultures’ (i.e.,
university-based researchers versus hospital-based clini-
cians) and making sure all views and expertise were con-
sidered [8]. Leaders’ perceptions of their role accord with
factors known to increase the success of transdisciplinary
or interorganisational teams: communicating the TRN’s vi-
sion, connecting and co-ordinating effort across diverse
groups, facilitating local project teams, and ensuring there
is understanding between the ‘two cultures.’
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